🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 12% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Softgel(s) Serving Size
90 Servings
Fat/Fatty Acid Product Type
12% Evidence Coverage

Supplement Facts — Evidence Check

Calories
14 Calorie(s)
Total Fat
2 Gram(s) (3% DV)
Cholesterol
Total Carbohydrate
Protein
0.46 Gram(s) (1% DV)
Calcium
12.6 mg (1% DV)
4.1 NP (1% DV)
📊 Market median: 99.0mg (503 products) 📚 12 studies (Tier A: 0, B: 3)
RDA 700mg This product: 4.1mg UL 4000mg
Safflower Oil
2000 mg

Other Ingredients

Gelatin Glycerin Water, Purified

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (98% of products) Structure/Function (89% of products) Nutrient (76% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Suggested Usage: As a dietary supplement, take 2 softgels, twice daily, between meals.

⚠️ Warnings & Precautions

Allergen Information: Not manufactured with yeast, wheat, corn, gluten, soy, milk, egg, fish, shellfish or tree nuts ingredients. Produced in a GMP facility that processes other ingredients containing these allergens.

Warnings: For adults only.

Consult physician if pregnant or nursing.

Please consult with your healthcare provider before beginning any new supplement, diet, training program or if you are undergoing treatment for a medical condition.

Keep out of reach of children.

Do not eat freshness packet. Keep in bottle.

🧪 Formulation Notes

CLA contains conjugated linoleic acid (CLA), a unique optical isomer of the polyunsaturated fatty acid linoleic acid. The CLA in this formulation is derived from non-GMO safflower seed oil.

Allergen Information: Not manufactured with yeast, wheat, corn, gluten, soy, milk, egg, fish, shellfish or tree nuts ingredients.

2000 mg of safflower oil contains a minimum of 80% CLA (Conjugated Linoleic Acid).

Conjugated Linoleic Acid 2000 mg per serving

Weight management Supports healthy muscle tone Supports healthy lipid levels

Contains no artificial colors and flavors

Made with Non GMO ingredients

Additional Information

Please recycle.

GMP Good Manufacturing Practice Consistent quality Made in USA

Product Details

UPC / SKU X0016AEDJX
DSLD Entry Date 2022-10-24
Product Type Fat/Fatty Acid
Form Softgel Capsule
DSLD ID 276077
Data Updated 2026-04-11

Research Evidence

46 Research Sources
55 Avg Quality Score
23 Meta Analysis
7 Systematic Review
7 Rct
4 Clinical Trial
2 Other
1 Guideline
1 Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024
View all evidence for Phosphorus →

Compare Similar Products

View all Phosphorus products →